Regulon

Regulon: R-292

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
173.13489121Pr-43Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7132 ENSG00000067182 TNFRSF1A P19438
6717 ENSG00000075142 SRI P30626
760 ENSG00000104267 CA2 P00918
1647 ENSG00000116717 GADD45A P24522
2012 ENSG00000134531 EMP1 P54849
389 ENSG00000155366 RHOC E9PLA2
8324 ENSG00000155760 FZD7 O75084
1827 ENSG00000159200 RCAN1 P53805
5806 ENSG00000163661 PTX3 P26022
9263 ENSG00000164543 STK17A Q9UEE5
81628 ENSG00000166925 TSC22D4 Q9Y3Q8
9122 ENSG00000168679 SLC16A4 O15374
30008 ENSG00000172638 EFEMP2 O95967
114897 ENSG00000173918 C1QTNF1 Q9BXJ1
1466 ENSG00000175183 CSRP2 Q16527
24147 ENSG00000179431 FJX1 Q86VR8
5021 ENSG00000180914 OXTR P30559

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
GSK-1995057TNFRSF1AAntibodyINHIBITORTumor necrosis factor receptor R1 inhibitor10
BRINZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
DORZOLAMIDE HYDROCHLORIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
DICHLORPHENAMIDECA4Small moleculeINHIBITORCarbonic anhydrase IV inhibitor40
SULTHIAMECA2Small moleculeINHIBITORCarbonic anhydrase inhibitor40
EPELSIBANOXTRSmall moleculeANTAGONISTOxytocin receptor antagonist20
DORZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
ACETAZOLAMIDECA4Small moleculeINHIBITORCarbonic anhydrase XII inhibitor40
METHAZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
OXYTOCINOXTRProteinAGONISTOxytocin receptor agonist40
CARBETOCINOXTRProteinAGONISTOxytocin receptor agonist40
NOLASIBANOXTRSmall moleculeANTAGONISTOxytocin receptor antagonist30
TOPIRAMATECA4Small moleculePOSITIVE MODULATORGABA-A receptor; anion channel positive modulator40
VANTICTUMABFZD5AntibodyANTAGONISTFrizzled-1 antagonist10
ATOSIBANOXTRProteinANTAGONISTOxytocin receptor antagonist40
FE 202767OXTRProteinAGONISTOxytocin receptor agonist20
BARUSIBANOXTRProteinANTAGONISTOxytocin receptor antagonist20
ACETAZOLAMIDE SODIUMCA4Small moleculeINHIBITORCarbonic anhydrase XII inhibitor40
POLMACOXIBPTGS2Small moleculeINHIBITORCarbonic anhydrase I inhibitor30
RETOSIBANOXTRSmall moleculeANTAGONISTOxytocin receptor antagonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-292

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00542HMCN1up-regulatesNFKB1activatesR-2922511Drugs (20)
CMF-01795TMPRSS15up-regulatesNFKB1activatesR-292254Drugs (20)
CMF-03692DSPup-regulatesNFKB1activatesR-2922513Drugs (20)
CMF-08248KIF4Adown-regulatesNFKB1activatesR-292258Drugs (20)
CMF-09474DOCK11up-regulatesNFKB1activatesR-292258Drugs (20)
CMF-11301RPTNup-regulatesNFKB1activatesR-292254Drugs (20)
CMF-12918HTR3Edown-regulatesNFKB1activatesR-292255Drugs (20)
CMF-14126CD1Dup-regulatesNFKB1activatesR-292252Drugs (20)
CMF-15612DCHS2up-regulatesNFKB1activatesR-292258Drugs (20)
CMF-15778GRM3up-regulatesNFKB1activatesR-292253Drugs (20)
CMF-16377SUSD5up-regulatesNFKB1activatesR-292256Drugs (20)
CMF-16694SIup-regulatesNFKB1activatesR-292251Drugs (20)
CMF-20540ADCY1up-regulatesNFKB1activatesR-292255Drugs (20)
CMF-21000KRTAP4-7up-regulatesNFKB1activatesR-2922511Drugs (20)
CMF-21312GRIK3up-regulatesNFKB1activatesR-292255Drugs (20)
CMF-24444SEMA3Cdown-regulatesNFKB1activatesR-292256Drugs (20)
CMF-26297CHGBup-regulatesNFKB1activatesR-292254Drugs (20)
CMF-27285CHD5up-regulatesNFKB1activatesR-292256Drugs (20)
CMF-29160AQP10down-regulatesNFKB1activatesR-2922510Drugs (20)
CMF-30043FAM126Bup-regulatesNFKB1activatesR-292254Drugs (20)
CMF-33674BCR_SIGNALING_PATHWAYup-regulatesNFKB1activatesR-292252Drugs (20)